Market Closed -
Bombay S.E.
06:12:34 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
395.2
INR
|
-1.20%
|
|
-2.18%
|
-4.21%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
8,029
|
7,671
|
4,130
|
8,535
|
9,494
|
9,519
|
Enterprise Value (EV)
1 |
7,607
|
6,929
|
3,930
|
8,065
|
9,687
|
9,833
|
P/E ratio
|
18.4
x
|
13.6
x
|
6.66
x
|
15.3
x
|
16.3
x
|
13.8
x
|
Yield
|
1.55%
|
1.71%
|
3.53%
|
1.71%
|
1.54%
|
1.53%
|
Capitalization / Revenue
|
2.89
x
|
2.5
x
|
1.35
x
|
2.77
x
|
1.94
x
|
1.71
x
|
EV / Revenue
|
2.74
x
|
2.26
x
|
1.28
x
|
2.62
x
|
1.98
x
|
1.77
x
|
EV / EBITDA
|
12.7
x
|
9.69
x
|
5.34
x
|
10.9
x
|
11.8
x
|
9.91
x
|
EV / FCF
|
32
x
|
41.5
x
|
-15
x
|
15,490
x
|
-18.9
x
|
-105
x
|
FCF Yield
|
3.12%
|
2.41%
|
-6.65%
|
0.01%
|
-5.29%
|
-0.96%
|
Price to Book
|
1.57
x
|
1.99
x
|
1.37
x
|
1.85
x
|
1.1
x
|
1.29
x
|
Nbr of stocks (in thousands)
|
29,200
|
29,200
|
29,200
|
29,200
|
29,200
|
29,200
|
Reference price
2 |
275.0
|
262.7
|
141.4
|
292.3
|
325.2
|
326.0
|
Announcement Date
|
5/30/18
|
7/3/19
|
6/26/20
|
6/17/21
|
6/29/22
|
6/26/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,774
|
3,069
|
3,062
|
3,082
|
4,904
|
5,566
|
EBITDA
1 |
600.8
|
715.1
|
736.2
|
738.6
|
822.4
|
992.6
|
EBIT
1 |
553.6
|
659.9
|
674
|
669.8
|
717.6
|
843.2
|
Operating Margin
|
19.96%
|
21.5%
|
22.01%
|
21.73%
|
14.63%
|
15.15%
|
Earnings before Tax (EBT)
1 |
634.1
|
803.7
|
776.2
|
749.5
|
776.1
|
909.1
|
Net income
1 |
436.4
|
564.8
|
620.1
|
557.9
|
583
|
692
|
Net margin
|
15.74%
|
18.41%
|
20.25%
|
18.1%
|
11.89%
|
12.43%
|
EPS
2 |
14.95
|
19.34
|
21.24
|
19.10
|
19.97
|
23.70
|
Free Cash Flow
1 |
237.5
|
166.8
|
-261.3
|
0.5206
|
-512.2
|
-93.99
|
FCF margin
|
8.56%
|
5.44%
|
-8.53%
|
0.02%
|
-10.44%
|
-1.69%
|
FCF Conversion (EBITDA)
|
39.54%
|
23.32%
|
-
|
0.07%
|
-
|
-
|
FCF Conversion (Net income)
|
54.43%
|
29.53%
|
-
|
0.09%
|
-
|
-
|
Dividend per Share
2 |
4.250
|
4.500
|
5.000
|
5.000
|
5.000
|
5.000
|
Announcement Date
|
5/30/18
|
7/3/19
|
6/26/20
|
6/17/21
|
6/29/22
|
6/26/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
193
|
314
|
Net Cash position
1 |
421
|
742
|
200
|
470
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
0.2348
x
|
0.3165
x
|
Free Cash Flow
1 |
238
|
167
|
-261
|
0.52
|
-512
|
-94
|
ROE (net income / shareholders' equity)
|
10.6%
|
12.6%
|
18%
|
14.6%
|
8.83%
|
8.68%
|
ROA (Net income/ Total Assets)
|
7.49%
|
8.3%
|
10.4%
|
8.89%
|
5.77%
|
5.62%
|
Assets
1 |
5,830
|
6,806
|
5,979
|
6,277
|
10,111
|
12,318
|
Book Value Per Share
2 |
175.0
|
132.0
|
104.0
|
158.0
|
294.0
|
252.0
|
Cash Flow per Share
2 |
4.890
|
9.310
|
6.750
|
24.00
|
10.20
|
10.90
|
Capex
1 |
197
|
189
|
419
|
427
|
688
|
604
|
Capex / Sales
|
7.1%
|
6.16%
|
13.68%
|
13.87%
|
14.03%
|
10.85%
|
Announcement Date
|
5/30/18
|
7/3/19
|
6/26/20
|
6/17/21
|
6/29/22
|
6/26/23
|
|
1st Jan change
|
Capi.
|
---|
| -4.21% | 138M | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|